Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Johnson & Johnson's Potential Depression Blockbuster Esketamine Shows Promise in Phase II Study

biospaceJanuary 02, 2018

Tag: Johnson & Johnson , depression

PharmaSources Customer Service